openPR Logo
Press release

Molecular Diagnostics Market Size & Trends

Molecular Diagnostics Market Size & Trends

Molecular Diagnostics Market Size & Trends

According to a new market research report published by Global Market Estimates, the Global Molecular Diagnostics Market is projected to grow from USD 23.41 billion in 2022 to USD 31.24 billion at a CAGR value of 5.8% from 2022 to 2027.
The major drivers of the molecular diagnostics market are the growing incidence of infectious diseases and genetic disorders among the population, increasing investment in the adoption of molecular diagnostic tests, advancements in testing techniques such as ddPCR, and the growing applicability of molecular diagnostic tests.

Browse 155 Market Data Tables and 133 Figures spread through 156 Pages and in-depth TOC on "Global Molecular Diagnostics Market - Forecast to 2027'' https://www.globalmarketestimates.com/market-report/molecular-diagnostics-market-3792

By Product (Instruments, Consumables), By Technology (PCR [Standard PCR, rtPCR], In Situ Hybridization, Chips & Microarrays, Mass Spectrometry (MS), Sequencing), By Application (Infectious Disease [COVID-19, Methicillin-resistant Staphylococcus Aureus (MRSA), Clostridium Difficile, Vancomycin-resistant Enterococci (VRE), Carbapenem-resistant Bacteria, Flu, Respiratory Syncytial Virus (RSV), Candida, Tuberculosis & Drug-resistant TB, Meningitis, Gastrointestinal Panel Testing, Chlamydia, Gonorrhea, HIV, Hepatitis C, Hepatitis B], Oncology [Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Blood Cancer, Lung Cancer], Neurological Disease, Cardiovascular Disease), By End-User (Hospitals & Clinics, Laboratories, Diagnostic Centers, Home Testing), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis

Key Market Insights
• As per the technology outlook, the PCR segment is expected to be the largest segment in the molecular diagnostics market from 2022 to 2027
• The Asia Pacific region is analyzed to be the fastest-growing segment in the market
• As per the application outlook, the oncology segment is expected to be the largest segment in the molecular diagnostics market from 2022 to 2027
• North America (the United States, Canada, and Mexico) will have a dominant share in the global Molecular Diagnostics market from 2022 to 2027
• Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, bioMérieux SA, Laboratory Corporation of America, Quest Diagnostics, Hologic, Inc., Abbott, Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., DiaSorin Company, Beckman Coulter Inc., BioFire Defense, LLC, Co-Diagnostics, Inc., Sysmex Corporation, Johnson & Johnson Services, Inc., Hologic Corporation, Illumina Ltd., PCR Biosystems, PCR-Dx, Curiosity Diagnostic, Genome Diagnostics Pvt. Ltd., Molbio Diagnostics Pvt. Ltd., 1drop Inc., Exact Sciences Laboratories, LumiraDx UK Ltd., and Sherlock BioSciences, Inc., among others, are the some of the key players in the molecular diagnostics market

Product Outlook (Revenue, USD Billion, 2022-2027)
• Instruments
• Consumables

Technology Size Outlook (Revenue, USD Billion, 2022-2027)
• PCR
• Standard PCR
• rtPCR
• Others
• In Situ Hybridization
• Chips and Microarrays
• Mass Spectrometry (MS)
• Sequencing
• Other Technologies

Application Size Outlook (Revenue, USD Billion, 2022-2027)
• Infectious Disease
• COVID-19
• Methicillin-resistant Staphylococcus Aureus (MRSA)
• Clostridium Difficile
• Vancomycin-resistant Enterococci (VRE)
• Carbapenem-resistant Bacteria
• Flu
• Respiratory Syncytial Virus (RSV)
• Candida
• Tuberculosis and Drug-resistant TB
• Meningitis
• Gastrointestinal Panel Testing
• Chlamydia
• Gonorrhea
• HIV
• Hepatitis C
• Hepatitis B
• Other Infectious Disease
• Oncology
• Breast Cancer
• Prostate Cancer
• Colorectal Cancer
• Cervical Cancer
• Kidney Cancer
• Liver Cancer
• Blood Cancer
• Lung Cancer
• Other Cancer
• Neurological Disease
• Cardiovascular Disease
• Others

End-User Outlook (Revenue, USD Billion, 2022-2027)
• Hospitals & Clinics
• Diagnostic Centers
• Home Testing
• Others

Regional Outlook (Revenue, USD Billion, 2022-2027)
North America
• The U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• UAE
• Rest of MEA

Contact: Yash Jain
Email address: yash.jain@globalmarketestimates.com
Phone Number: +1 6026667238

B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India

Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Molecular Diagnostics Market Size & Trends here

News-ID: 2625944 • Views: 319

More Releases from Global Market Estimates Research & Consultants

Global Cardiac Electrophysiology Market Size - Forecasts to 2027
According to a new market research report published by Global Market Estimates, the Global Cardiac Electrophysiology Market is projected to grow at a CAGR value of 14.6% from 2022 to 2027. The growth of the global electrophysiology market can be attributed to factors such as increasing technological advancements in the field of CVD diagnostics; new entrants in the market; growing investments, funds, and grants; and an increased incidence of target
Global Organic Solar Cell Market Size - Forecasts to 2027
According to a new market research report published by Global Market Estimates, the Global Organic Solar Cell Market is projected to grow at a CAGR value of 13.5% from 2022 to 2027. The OPV market will be highly driven by increasing demand for sufficient electricity in developing and under-developed countries, rising need for renewable and sustainable sources of energy, growing awareness regarding integrating electricity into different products and increasing government
Global Digital Payments Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Digital Payments Market is projected to grow from USD 88.1 billion in 2022 to USD 180.2 billion by 2027, at a CAGR of 15.4%. Market expansion is being fuelled by the rising use of mobile wallets, rising customer acceptability of digital payment methods, the incumbent government's aim on establishing a cashless society, and constantly emerging smartphone and
Global Smart Watch Market Size - Forecasts to 2027
According to a new market research report published by Global Market Estimates, the Global Smart Watch Market is projected to grow from USD 22.5 Billion in 2022 to USD 96.6 Billion in 2027 at a CAGR value of 22.5% from 2022 to 2027. Growing emphasis for connected devices among various industries, and increasing demand for connected ecosystem are expected to offer lucrative smartwatch market growth globally. Browse 151 Market Data Tables

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include: 1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and